Aethlon Medical, Inc.
AEMD
$1.59
$0.042.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.58M | -13.39M | -9.56M | -11.27M | -11.50M |
| Total Depreciation and Amortization | 336.10K | 339.60K | 341.50K | 349.20K | 354.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.32M | 5.31M | 708.40K | 1.12M | 1.13M |
| Change in Net Operating Assets | -686.50K | 93.60K | -29.60K | 892.10K | 620.30K |
| Cash from Operations | -7.61M | -7.65M | -8.54M | -8.91M | -9.39M |
| Capital Expenditure | 0.00 | 0.00 | -7.10K | -13.70K | -20.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -7.10K | -13.70K | -20.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.53M | 7.91M | 5.43M | 5.62M | 5.62M |
| Repurchase of Common Stock | -19.20K | -18.90K | -23.20K | -25.50K | -31.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -164.90K | -164.90K | -- | -- | -- |
| Cash from Financing | 2.34M | 7.73M | 5.41M | 5.60M | 5.59M |
| Foreign Exchange rate Adjustments | -26.40K | -12.20K | -12.10K | 7.10K | 900.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.30M | 69.60K | -3.15M | -3.32M | -3.83M |